Source access required
CVR360 has not loaded official Danish source data for this company yet. No AI or financial conclusion is generated without source-backed facts.
MB
MCT Bioseparation Aps
aktivCVR 41269774AnpartsselskabHollandsvej 5H, st, 2800 Kongens LyngbyForskning og eksperimentel udvikling inden for naturvidenskab og teknik
- Latest accounts
- 2025
- Statement scope
- Standalone
- Verified
- 05 Nov 2026
- Sources
- 5
What changed?
Source-backed changes, not an assessment.
1 source
Key figures
Latest period: 2025
Revenue
DKK 138.6k
Revenue growth: 56,526.5%
Source details
Source: dk-regnskabsdata-live-41269774-1793897417410
Document: dk-regnskabsdata-41269774-AZ8aHbDRcguJTV-xG8pn-1
XBRL: fsa:Revenue
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c0
Unit: u0
Operating profit
-DKK 78
Latest period
Source details
Source: dk-regnskabsdata-live-41269774-1793897417410
Document: dk-regnskabsdata-41269774-AZ8aHbDRcguJTV-xG8pn-1
XBRL: fsa:ProfitLossFromOrdinaryOperatingActivities
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c0
Unit: u0
Net result
-DKK 42
Latest period
Source details
Source: dk-regnskabsdata-live-41269774-1793897417410
Document: dk-regnskabsdata-41269774-AZ8aHbDRcguJTV-xG8pn-1
XBRL: fsa:ProfitLoss
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c0
Unit: u0
Equity
DKK 50k
Equity ratio: 87.7%
Source details
Source: dk-regnskabsdata-live-41269774-1793897417410
Document: dk-regnskabsdata-41269774-AZ8aHbDRcguJTV-xG8pn-1
XBRL: fsa:Equity
Period: 01 Jan 2025 - 31 Dec 2025
Technical details
Context: c3
Unit: u0
Development
Reported values. Missing periods appear as gaps.
RevenueNet result
Tabular view of development
| Year | Revenue | Net result |
|---|---|---|
| 2022 | DKK 519.2k | DKK -56.1k |
| 2023 | DKK 250.5k | DKK 55.1k |
| 2024 | DKK 245 | DKK 38 |
| 2025 | DKK 138.6k | -DKK 42 |